Mydecine Announces First Quarter 2022 Financial Results and Highlights

Mydecine Announces First Quarter 2022 Financial Results and Highlights

Mydecine (MYCO) announced a $5.6M net loss and $264.7K cash position as of the end of Q1 (March 31), but has since raised an additional $1.65M in financing.

PDF of article